| Literature DB >> 36169648 |
Victor Omollo1, Stephanie D Roche2, Felix Mogaka3, Josephine Odoyo4, Gena Barnabee4, Elizabeth A Bukusi5, Ariana W K Katz6, Jennifer Morton7, Rachel Johnson8, Jared M Baeten9, Connie Celum10, Gabrielle O'Malley11.
Abstract
Daily oral pre-exposure prophylaxis (PrEP) is being incorporated into services frequented by adolescent girls and young women (AGYW) in sub-Saharan Africa who are at a significant risk of HIV. In non-PrEP studies, positive provider-client rapport has been shown to improve patient decision-making and use of medication in clinical care. We examined AGYW and healthcare provider (HCP) perspectives on the value of and strategies for building positive provider-client rapport. We conducted in-depth interviews from January 2018 to December 2019 with 38 AGYW and 15 HCPs from two family planning clinics in Kisumu, Kenya where PrEP was being delivered to AGYW as part of the Prevention Options for Women Evaluation Research (POWER) study. We used semi-structured interview guides and audio-recorded interviews with participant consent. Verbatim transcripts were analysed using thematic content analysis. HCPs and AGYW emphasised the importance of positive provider-client rapport to meet AGYW support needs in PrEP service delivery. HCPs described how they employed rapport-building strategies that strengthened AGYW PrEP uptake and continuation, including: (1) using friendly and non-judgmental tones; (2) maintaining client confidentiality (to build client trust); (3) adopting a conversational approach (to enable accurate risk assessment); (4) actively listening and tailoring counselling (to promote client knowledge, skills, and self-efficacy); and (5) supporting client agency. Positive provider-client relationships and negative experiences identified in this analysis have the potential to facilitate/deter AGYW from using PrEP while at risk. The strategies to enhance provider-client rapport identified in this study could be integrated into PrEP provider training and delivery practices.Entities:
Keywords: HIV prevention; Kenya; adolescent girls and young women; counselling; delivery of health care; health provider–patient relations; implementation science; pre-exposure prophylaxis; support needs; youth-friendly services
Mesh:
Substances:
Year: 2022 PMID: 36169648 PMCID: PMC9542727 DOI: 10.1080/26410397.2022.2095707
Source DB: PubMed Journal: Sex Reprod Health Matters ISSN: 2641-0397
Characteristics of interviewed health care providers and adolescent girls and young women
| 1. Health care providers | |
|---|---|
| Health care providers interviewed | 15 |
| Median age (IQR) | 30 (29–42) |
| Female | 9 (60%) |
| POWER staff | 10 (67%) |
| Primary role during POWER study | |
| Health care provider | 10 (67%) |
| HIV testing services counsellor | 3 (30%) |
| Clinician | 6 (60%) |
| Adherence counsellor | 1 (10%) |
| Other key informant | 5 (33%) |
| Adolescent girls and young women interviewed | 38 |
| Median age (IQR) | 21 (19–24) |
| Single marital status | 22 (58%) |
| Median number of living children | 1 (0–1) |
| Multiple sexual partners | 8 (21%) |
| Unknown partner HIV status | 21 (55%) |
| Condom use | |
| Always | 4 (11%) |
| Never | 16 (42%) |
| Inconsistent | 18 (47%) |
| 10 (26%) | |
| Yes | 4 (11%) |
| No | 2 (5%) |
| Don’t know | 32 (84%) |
| 5 (13%) | |
| 25 (65%) |
Includes nurses and doctors/medical officers
Includes individuals whose primary role in POWER focused on research activities (as opposed to direct service provision) as well as individuals who were not directly involved in POWER but who, through their involvement in PrEP delivery in the region, could potentially provide relevant information about Kenya’s PrEP delivery landscape and/or PrEP delivery to Kenyan AGYW.
IQR – interquartile range.
POWER – prevention options for women evaluation research.
Categories of adolescent girls and young women interviewed
| Participant category | Definition | Number interviewed ( | Median duration on PrEP in days (interquartile range) |
|---|---|---|---|
| Initial refusers | Participants who declined PrEP at enrolment (but may or may not have started later) | 10 (26%) | 0 |
| Non-continuous users | Participants who initiated PrEP at enrolment and had a recently scheduled month 3 or month 6 visit and pharmacy records indicate late (within 30 days of scheduled pick-up), missed (did not completely attend their next scheduled pick-up) or declined PrEP pill pick-up | 9 (23%) | 93 (86–150) |
| Continuous users | Participants who initiated PrEP at enrolment and continued PrEP use over 6-month period with no gaps in pill coverage based on pill dispensing records | 7 (18%) | 108 (93–120) |
| Initial acceptors | Participants who initiated PrEP at enrolment | 6 (15%) | 47 (42–47) |
| Special cases | Participants whose unique circumstances or perspectives stood out and whose experiences could inform PrEP delivery, including participants who sero-converted to HIV | 4 (10%) | 145 (70–188) |
| Restarters | Participants who initiated PrEP and pharmacy records show a break in PrEP use for more than 30 days before a PrEP pill pick-up at a later clinic visit | 2 (5%) | 118 (118–118) |